首页 > 最新文献

Cancer Discovery最新文献

英文 中文
ALK+/EGFRm NSCLC: Lorlatinib Wows; Toward Sub-Q Amivantamab ALK+/EGFRm NSCLC:洛拉替尼(Lorlatinib)大放异彩,阿米万他单抗(Amivantamab)崭露头角
Pub Date : 2024-06-02 DOI: 10.1158/2159-8290.cd-nw2024-0035
Alissa Poh
{"title":"ALK+/EGFRm NSCLC: Lorlatinib Wows; Toward Sub-Q Amivantamab","authors":"Alissa Poh","doi":"10.1158/2159-8290.cd-nw2024-0035","DOIUrl":"https://doi.org/10.1158/2159-8290.cd-nw2024-0035","url":null,"abstract":"","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"44 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141273754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuing the Conversation. 继续对话。
Pub Date : 2024-04-04 DOI: 10.1158/2159-8290.CD-24-0154
Luis A. Diaz, Lewis C. Cantley
{"title":"Continuing the Conversation.","authors":"Luis A. Diaz, Lewis C. Cantley","doi":"10.1158/2159-8290.CD-24-0154","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-24-0154","url":null,"abstract":"","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"28 4","pages":"550-551"},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140746166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer Hallmarks: Piecing the Puzzle Together. 癌症标志:拼凑拼图
Pub Date : 2024-04-04 DOI: 10.1158/2159-8290.CD-24-0097
M. Alcolea, Direna Alonso-Curbelo, Chiara Ambrogio, S. Bullman, Ana Luísa Correia, Aurélie Ernst, Christopher J. Halbrook, G. Kelly, Amanda W Lund, D. Quail, M. Ruscetti, E. Shema, Ingunn M. Stromnes, Wai Leong Tam
{"title":"Cancer Hallmarks: Piecing the Puzzle Together.","authors":"M. Alcolea, Direna Alonso-Curbelo, Chiara Ambrogio, S. Bullman, Ana Luísa Correia, Aurélie Ernst, Christopher J. Halbrook, G. Kelly, Amanda W Lund, D. Quail, M. Ruscetti, E. Shema, Ingunn M. Stromnes, Wai Leong Tam","doi":"10.1158/2159-8290.CD-24-0097","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-24-0097","url":null,"abstract":"","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"11 18","pages":"674-682"},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140745580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pembrolizumab May Enhance Current Treatments for Esophagogastric Cancers. Pembrolizumab可增强食管胃癌的现有治疗方法
Pub Date : 2020-07-01 DOI: 10.1158/2159-8290.CD-RW2020-079
Anti-PD-1 was safe to add to anti-HER2 plus chemotherapy in HER2-positive esophagogastric cancers.
对于HER2阳性食管胃癌患者,在抗HER2加化疗的基础上加用抗PD-1是安全的。
{"title":"Pembrolizumab May Enhance Current Treatments for Esophagogastric Cancers.","authors":"","doi":"10.1158/2159-8290.CD-RW2020-079","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-RW2020-079","url":null,"abstract":"Anti-PD-1 was safe to add to anti-HER2 plus chemotherapy in HER2-positive esophagogastric cancers.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"3 2","pages":"901"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141202318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FBP1 Is a Tumor Suppressor Linking Hepatic Metabolism to Tumorigenesis. FBP1 是连接肝脏代谢与肿瘤发生的肿瘤抑制因子
Pub Date : 2020-07-01 DOI: 10.1158/2159-8290.CD-RW2020-071
Loss of the gluconeogenic enzyme FBP1 promoted hepatocellular carcinoma development in mice.
葡萄糖生成酶 FBP1 的缺失会促进小鼠肝细胞癌的发展。
{"title":"FBP1 Is a Tumor Suppressor Linking Hepatic Metabolism to Tumorigenesis.","authors":"","doi":"10.1158/2159-8290.CD-RW2020-071","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-RW2020-071","url":null,"abstract":"Loss of the gluconeogenic enzyme FBP1 promoted hepatocellular carcinoma development in mice.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"19 1","pages":"OF13"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141204899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Metastasis Has Multiple Origins and Occurs Early in Tumorigenesis. 转移有多种起源,并在肿瘤发生的早期出现。
Pub Date : 2020-07-01 DOI: 10.1158/2159-8290.CD-RW2020-082
Whether metastases were seeded mono- or polyclonally depended on cancer site and treatment.
转移瘤是单克隆还是多克隆播种取决于癌症部位和治疗方法。
{"title":"Metastasis Has Multiple Origins and Occurs Early in Tumorigenesis.","authors":"","doi":"10.1158/2159-8290.CD-RW2020-082","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-RW2020-082","url":null,"abstract":"Whether metastases were seeded mono- or polyclonally depended on cancer site and treatment.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"5 7","pages":"903"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141202163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-Infiltrating T Cells Mimic Tissue-Resident T-cell Heterogeneity. 肿瘤浸润 T 细胞模拟组织常驻 T 细胞异质性
Pub Date : 2020-05-29 DOI: 10.1158/2159-8290.CD-RW2020-080
Tissue-resident memory T cells and tumor-infiltrating lymphocytes (TIL) partitioned into two types.
组织驻留记忆 T 细胞和肿瘤浸润淋巴细胞(TIL)分为两种类型。
{"title":"Tumor-Infiltrating T Cells Mimic Tissue-Resident T-cell Heterogeneity.","authors":"","doi":"10.1158/2159-8290.CD-RW2020-080","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-RW2020-080","url":null,"abstract":"Tissue-resident memory T cells and tumor-infiltrating lymphocytes (TIL) partitioned into two types.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141202315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
T-cell Exhaustion Is an Epigenetically Driven Multistage Process. T 细胞衰竭是表观遗传学驱动的多阶段过程
Pub Date : 2020-05-22 DOI: 10.1158/2159-8290.CD-RW2020-077
T-cell exhaustion was a four-stage process; the transition to terminal exhaustion was irreversible.
T 细胞衰竭分为四个阶段;过渡到最终衰竭是不可逆的。
{"title":"T-cell Exhaustion Is an Epigenetically Driven Multistage Process.","authors":"","doi":"10.1158/2159-8290.CD-RW2020-077","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-RW2020-077","url":null,"abstract":"T-cell exhaustion was a four-stage process; the transition to terminal exhaustion was irreversible.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"81 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141203605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mutant EZH2 Drives Follicular Lymphoma by Altering B-cell Dependencies. 突变 EZH2 通过改变 B 细胞依赖性诱发滤泡性淋巴瘤
Pub Date : 2020-05-22 DOI: 10.1158/2159-8290.CD-RW2020-074
Ezh2-mutant germinal center B cells depended on follicular dendritic cells rather than Tfh cells.
Ezh2突变的生殖中心B细胞依赖于滤泡树突状细胞,而不是Tfh细胞。
{"title":"Mutant EZH2 Drives Follicular Lymphoma by Altering B-cell Dependencies.","authors":"","doi":"10.1158/2159-8290.CD-RW2020-074","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-RW2020-074","url":null,"abstract":"Ezh2-mutant germinal center B cells depended on follicular dendritic cells rather than Tfh cells.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"79 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141203628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Differentiation of Cancer Stem Cells Halts Protein and rRNA Synthesis. 癌症干细胞的分化会停止蛋白质和 rRNA 的合成
Pub Date : 2020-05-22 DOI: 10.1158/2159-8290.CD-RW2020-075
Colorectal cancer cells lost biosynthetic capabilities in an irreversible differentiation process.
大肠癌细胞在不可逆的分化过程中丧失了生物合成能力。
{"title":"Differentiation of Cancer Stem Cells Halts Protein and rRNA Synthesis.","authors":"","doi":"10.1158/2159-8290.CD-RW2020-075","DOIUrl":"https://doi.org/10.1158/2159-8290.CD-RW2020-075","url":null,"abstract":"Colorectal cancer cells lost biosynthetic capabilities in an irreversible differentiation process.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"81 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141203608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cancer Discovery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1